PHR: Phreesia Inc

PHR新闻

• 19:47 巴克莱维持对 Phreesia 的“持平大盘”评级，将目标价上调至 11 美元
• 19:47 Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
• 12:07 Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
• 14:24 These Analysts Revise Their Forecasts On Phreesia After Q2 Results - Phreesia (NYSE:PHR)
• 23:34 Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
• 22:00 Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
• 21:10 Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
• 21:20 Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates
• 00:15 NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
• 12:50 ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
• 11:35 Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
• 00:35 Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
• 13:40 Should Value Investors Buy Phreesia (PHR) Stock?
• 12:39 Phreesia: Rating Downgrade As Growth Outlook Worsens (NYSE:PHR)
• 13:40 Are Investors Undervaluing Phreesia (PHR) Right Now?